Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raakow

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|March 27, 2001
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantationJ M Langrehr, R Lohmann, O Guckelberger, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Transplantation Proceedings|December 1, 1996
Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized studyJ M Langrehr, O Guckelberger, N Nüssler, et al.
Pageof 5